Weight Loss

Assessing Mechanism, Risks of Semaglutide, the Weight Loss Drug Credited by Elon Musk

Assessing Mechanism, Risks of Semaglutide, the Weight Loss Drug Credited by Elon Musk
This photograph taken on February 23, 2023, in Paris, shows the anti-diabetic medication "Ozempic" (semaglutide) made by Danish pharmaceutical company "Novo Nordisk". Photo by Joel Sage/AFP via Getty Images
David Chu
|Updated:
0:00

Ozempic and Wegovy, launched by the Danish pharmaceutical company Novo Nordisk, have received much praise on social media outlets as “magic weight loss drugs” by some people who are keen to lose weight.

They both contain semaglutide as the main ingredient. Tesla CEO Elon Musk once said on Twitter that in addition to paying attention to his diet, he also used Ozempic and Wegovy, which is one of the secrets to his successful 30-pound weight loss.

David Chu
David Chu
Author
David Chu is a London-based journalist who has been working in the financial sector for almost 30 years in major cities in China and abroad, including South Korea, Thailand, and other Southeast Asian countries. He was born in a family specializing in Traditional Chinese Medicine and has a background in ancient Chinese literature.
Related Topics